Wear debris-induced
osteolysis and ensuing aseptic loosening is the main cause of implant failure and
revision surgery. Wear debris-induced inflammatory response plays key roles in peri-implant
osteolysis. Recently, substantial of evidence suggests that
hydrogen sulfide (H2 S), the third
gasotransmitter, is a critical player regulating
inflammation. However, the role and therapeutic potential of H2 S in wear debris-induced
inflammation and
osteolysis remains to be defined. In the present study, we investigated the effect of H2 S on wear debris-induced pro-inflammatory
cytokines expression and
osteolysis in vitro and in vivo. With a slow-releasing H2 S donor
GYY4137, our study demonstrated that H2 S attenuated wear debris-induced
osteolysis and osteoclastogenesis in murine calvaria resorption models. The expression of
tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and
interleukin-6 (IL-6) that stimulated by wear particles were significantly reduced by
GYY4137. Further, the level of
sirtuin 1 (
SIRT1), which possesses anti-
inflammation property, was examined in vivo and in macrophages. And we found that wear debris decreased the expression of
SIRT1. Cotreated macrophages with
GYY4137 in part reversed the decline of
SIRT1. More importantly, with the
SIRT1 recombinant lentivirus and small interfering RNAs (
siRNA) against
SIRT1, our data indicated that
SIRT1 mediated the inhibitory effects of
GYY4137 on wear debris-induced
inflammation. Collectively, these results suggested that exogenous H2 S production (via H2 S donors) may represent a potential approach for the treatment of wear particle-induced
osteolysis.